pyrazines has been researched along with Adult Fanconi Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, G; Liu, L; Wang, SX; Wang, Y; Yao, Y; Zhang, YK | 1 |
| Iwama, K; Matsue, K; Nishida, Y; Takeuchi, M; Yamakura, M | 1 |
2 other study(ies) available for pyrazines and Adult Fanconi Syndrome
| Article | Year |
|---|---|
Acquired Fanconi syndrome with proximal tubular cytoplasmic fibrillary inclusions of λ light chain restriction.
Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Boronic Acids; Bortezomib; Cytoplasm; Dexamethasone; Fanconi Syndrome; Humans; Immunoglobulin Light Chains; Kidney Tubules, Proximal; Male; Microscopy, Fluorescence; Microscopy, Immunoelectron; Multiple Myeloma; Myeloma Proteins; Phagosomes; Proteinuria; Pyrazines; Thalidomide | 2014 |
Renal Fanconi syndrome as a cause of chronic kidney disease in patients with monoclonal gammopathy of undetermined significance: partially reversed renal function by high-dose dexamethasone with bortezomib.
Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fanconi Syndrome; Humans; Kidney; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Pyrazines; Renal Insufficiency, Chronic; Treatment Outcome | 2012 |